NVDC Tx II Flashcards

1
Q

what are time frames for acute, persistant and chronic diarrhea

A

acute 14 days

chronic >30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what viruses and bacteria cause acute diarrhea

A

norwalk, rotavirus
shigella, salmonella, campylobacter, staph, e coli
don’t forget protozoa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what drugs induce diarrhea

A

reserpine, sulfonamides, tetracylcines, broad spec antibiotics, cholinergic agonists, osmoitc and stimulant laxatives, prokinetic agents, PGs and quinidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MOA loperamide

A

inhibit presynaptic cholinergic nerves in submucosal and myenteric plexuses, increase transit time, increase fecal water absorption, decrease mass colonic movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

why is loperamoid non prescription even though opiod

A

does not cross bbb
no analgesic properties
no potential for addiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

therapeutic use loperamide

A

mainstay nonspecific Tx diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adverse effects loperamide

A

toxic megacolon in those with active IBD

not used in patieints with ulcerative colitis or acute bacillary or amoebic dysentery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is ocreotide and MOA

A

somatostatin analog

inhibits secretion of hormones and transmitters because it acts like somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

therapeutic use ocreotide

A

those with advanced symotomatic tumors
diarrhea due to vagotomy or dumpign syndrome as well as diarrhea for short bowel syndrome or AIDS
used in small doses to stimulate motility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

adverse effects ocreotide

A

inhibits pancreatic secretion
nausea, abdominal pain, flatulence, diarrhea
can cause gallstones
hyperglycemia, hypothyroidism, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when do you not use anti diarrheals

A

bloody diarrhea, high fever, systemic toxicity

if diarrhea worsens with Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is criteria for constipation

A

<3 bowel movement per week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what drugs can induce constipation

A

opiog analgesics, antichoinergics, antacids with Al or CaCo, Fe and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

most important feature of Tx for constipation

A

dietary modification (increase fiber)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

first line for constipation prevention

A

bulk forming laxatives and docusates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

types of bulk forming laxatives

A

metamucil, citrucel, fiber con etc…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA bulk forming laxatives

A

indigestible, hydrophilic colloids which absorb water that forms a gel that distends colon and promotes peristalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

adverse effects bulk formint laxatives

A

bloating and flatus

need to take in suffiecient fluid to avoid obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the stool softeners

A

docusate oral or enema and glycerin suppository

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MOA stool softener

A

allows water and lipids to prenetrate stool which softens it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

therapeutic use stool softeners

A

to prevent constipatino and minimize straining (post operative patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is used to prevent and treat fecal impaction

A

mineral oil

23
Q

MOA osmotic liaxatives

A

soluble non absorbable, increase stool liquidity

24
Q

therapeutic use of non-absorbable sugars or salts

A

Tx acute constipation

prevent chronic constipation

25
Q

why is MgOH not used prolonged in patients with renal insufficiency

A

hyper Mg

26
Q

adverse effects of sorbitol and lactulose

A

severe flatus and cramps

27
Q

types of osmotic laxatives

A

Mgcitrate, MgOH, NaPO4,

polyethylene glycol

28
Q

adverse effects NaPO4

A

cardiac arrhythmias from hpokalemia, hypernatremia, hypocalcemia, hyperphosphatemia
can lead to acute renal fialure from CaPO4 deposition

29
Q

What is used for colon cleansing before procedure

A

polyethylene glycol

30
Q

MOA polyethylene glycol

A

isotonic fluid, contains inert osmotically active sugar with Nasulfate, NaCl, NaHCO3, KCl
ingest 2-4 L over 2-4 hours

31
Q

MOA stimulant laxatives

A

direct stimulation Enteric nervous system and colonic electrolyte and fluid secretion

32
Q

therapeutic use stimulant laxatives

A

not 1st line

intermittend use from patients who do not respond to bulking and osmoitc agents

33
Q

risks of long term use stimulant laxatives

A

dependence and destruction of mesenteric plexus resulting in colonic atony and dilation

34
Q

what are the anthraquinone derivavties

A

aloe, senna, cascara

35
Q

what are the diphenylmethane derivatives?

used for?

A

bisacodyl tab or suppository

used with PEG for colonic cleansing prior to colonscopy

36
Q

What is used in patients with chronic constipation who fail to conventional 1st line therapy

A

chloride channel activator that stimulates Cl in small intestine increasing motility

37
Q

MOA opiod R antagonists

A

inhibit opoid R
do not cross bbb
inhibits peripheral without analgesic effects

38
Q

therapeutic use methylnaltrexone

A

opoid antagonist
approved for opiod induced constipation
subcut

39
Q

contraindication methynaltrexone

A

GI obstruction

40
Q

what is used short term to shorten period of post operative ileus

A

alvimopan

41
Q

what is use of serotonin R agonist

A

increase GI motility and cardiac rate

enhance LES pressure and peristalsis, accelerates gastric emptying

42
Q

What is linaclotide and MOA

A

guanylate cyclase C agonist
binds g cyclase on luminal surface intestine and increases cGMP which increase Cl and HCO3 secretion increasing intestinal fluid and dec GI transit time

43
Q

what is used for chronic idiopathic constipation and IBS with constipation >18 y.o

A

linaclotide

44
Q

diabetic gastroparesis is common finding in which DM

A

II

45
Q

what prokinetic agents are available for GI

A

metoclopramide and serotoni agonists and erythromycin/macrolides

46
Q

MOA metoclopramide

A

central and peripheral dopamine R antagonist, serotonin agonist, serotonin antagonists, cholinesterase inhibitor

47
Q

metoclopramide does what

A

enhances motility of upper GI tract, accelerates gastric emptying, increases esophageal peristalsis, increases LES pressure

48
Q

therapeutic use metoclopramide

A

prior to meals and at bedtime to control nausea and vomiting

49
Q

adverse effects metoclopramide

A

cross bbb so extrapyramidal Sx: tardive dyskinesia
restlessness, drowsiness, insomnia, anxiety, agitation, depression
hyperprolactinemia can cause galactorrhea, breast tenderness and menstrual irregularities

50
Q

What is adverse effect of serotonin agonists for prokinetic GI

A

fatal cardiac arryhthmias

51
Q

MOA erythromcyin and macrolids for prokinetic GI

A

agonist at motilin T increased frequency and amplitude of antral contractions and initiats gastric phase III contractions

52
Q

therapeutic use erythromycin

A

short term improvement gastric emptying in diabetic gastroparesis
long term limited by concerns about toxicity, pseudomembranous colitis and induction of resistant bacterial strains, development of tolerance

53
Q

adverse effects of erythromycin

A

abdominal pain, cramping, nausea, diarrhea, vomiting
malabsorption
tolerance develops rapidly (motilin downregulation)